↓ Skip to main content

Cilostazol for intermittent claudication

Overview of attention for article published in Cochrane database of systematic reviews, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
12 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
248 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cilostazol for intermittent claudication
Published in
Cochrane database of systematic reviews, October 2014
DOI 10.1002/14651858.cd003748.pub4
Pubmed ID
Authors

Rachel Bedenis, Marlene Stewart, Marcus Cleanthis, Peter Robless, Dimitri P Mikhailidis, Gerard Stansby

Abstract

Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication, characterised by pain in the legs or buttocks that occurs with exercise and which subsides with rest. Compared with age-matched controls, people with intermittent claudication have a three- to six-fold increase in cardiovascular mortality. Symptoms of intermittent claudication, walking distance, and quality of life can be improved by risk factor modification, smoking cessation, and a structured exercise programme. Antiplatelet treatment is beneficial in patients with intermittent claudication for the reduction of vascular events but has not previously been shown to influence claudication distance. This is an update of a review first published in 2007.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 248 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 2 <1%
Canada 1 <1%
Spain 1 <1%
Colombia 1 <1%
Unknown 241 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 19%
Researcher 33 13%
Student > Bachelor 26 10%
Student > Doctoral Student 24 10%
Student > Ph. D. Student 23 9%
Other 46 19%
Unknown 48 19%
Readers by discipline Count As %
Medicine and Dentistry 107 43%
Nursing and Health Professions 24 10%
Social Sciences 9 4%
Agricultural and Biological Sciences 8 3%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 30 12%
Unknown 63 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#1,882,042
of 14,738,308 outputs
Outputs from Cochrane database of systematic reviews
#4,618
of 11,034 outputs
Outputs of similar age
#33,613
of 233,313 outputs
Outputs of similar age from Cochrane database of systematic reviews
#121
of 252 outputs
Altmetric has tracked 14,738,308 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,034 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.6. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.